Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Yu

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
The Oncologist|March 26, 2017
Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast CancerAnthony F Yu, Jasmeet C Singh, Rui Wang, et al.
JACC. Cardiooncology|June 19, 2025
Lung Cancer and Cardiovascular Disease: Common Pathophysiology and Treatment-Emergent ToxicityMalak El-Rayes, Inbar Nardi Agmon, Christopher Yu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 8, 2017
Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell TransplantationShawn C Pun, Heather J Landau, Elyn R Riedel, et al.
JACC. Cardiooncology|October 29, 2020
Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL AmyloidosisKatherine Lee Chuy, Esther Drill, Ji Can Yang, et al.
JAMA Cardiology|May 31, 2023
Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy-Related Cardiac Dysfunction in Patients Undergoing Treatment for ERBB2-Positive Breast CancerAnthony F Yu, Zachary R Moore, Chaya S Moskowitz, et al.
The Oncologist|August 5, 2015
Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular DysfunctionAnthony F Yu, Nandini U Yadav, Anne A Eaton, et al.
JAMA Cardiology|January 16, 2020
Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast CancerAnthony F Yu, Jessica R Flynn, Chaya S Moskowitz, et al.
The Oncologist|March 18, 2016
Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast CancerAnthony F Yu, Carlos Manrique, Shawn Pun, et al.
Biomed Research International|March 5, 2016
Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult CancerAnthony F Yu, Jayant Raikhelkar, Emily C Zabor, et al.
Journal of the American Heart Association|September 26, 2023
Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast CancerAnthony F Yu, I-Hsin Lin, Justine Jorgensen, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
The Oncologist|March 26, 2017
Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast CancerAnthony F Yu, Jasmeet C Singh, Rui Wang, et al.
JACC. Cardiooncology|June 19, 2025
Lung Cancer and Cardiovascular Disease: Common Pathophysiology and Treatment-Emergent ToxicityMalak El-Rayes, Inbar Nardi Agmon, Christopher Yu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 8, 2017
Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell TransplantationShawn C Pun, Heather J Landau, Elyn R Riedel, et al.
JACC. Cardiooncology|October 29, 2020
Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL AmyloidosisKatherine Lee Chuy, Esther Drill, Ji Can Yang, et al.
JAMA Cardiology|May 31, 2023
Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy-Related Cardiac Dysfunction in Patients Undergoing Treatment for ERBB2-Positive Breast CancerAnthony F Yu, Zachary R Moore, Chaya S Moskowitz, et al.
The Oncologist|August 5, 2015
Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular DysfunctionAnthony F Yu, Nandini U Yadav, Anne A Eaton, et al.
JAMA Cardiology|January 16, 2020
Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast CancerAnthony F Yu, Jessica R Flynn, Chaya S Moskowitz, et al.
The Oncologist|March 18, 2016
Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast CancerAnthony F Yu, Carlos Manrique, Shawn Pun, et al.
Biomed Research International|March 5, 2016
Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult CancerAnthony F Yu, Jayant Raikhelkar, Emily C Zabor, et al.
Journal of the American Heart Association|September 26, 2023
Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast CancerAnthony F Yu, I-Hsin Lin, Justine Jorgensen, et al.
Pageof 7